Related Experiment Videos
Chronic dysrhythmias: a new look at old questions
Progress in Cardiovascular Diseases
|September 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades.
Journal of the American College of Cardiology·1998
beta-adrenergic and cholinergic modulation of the inwardly rectifying K+ current in guinea-pig ventricular myocytes.
The Journal of physiology·1995
Electrophysiology of adult cat cardiac ventricular myocytes: changes during primary culture.
The American journal of physiology·1995
Alteration of the sodium current in cat cardiac ventricular myocytes during primary culture.
The American journal of physiology·1995
An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes.
Journal of molecular and cellular cardiology·1995
Obesity, lipids, inflammation, and healthy aging.
Progress in cardiovascular diseases·2026
Revascularization options for managing patients with multi-vessel coronary artery disease.
Progress in cardiovascular diseases·2026
Transcatheter versus surgical pulmonary valve replacement in native RVOT: A 3-year propensity score-matched study.
Progress in cardiovascular diseases·2026
Large language models in sports cardiology: Challenges, governance, and human-in-the-loop integration.
Progress in cardiovascular diseases·2026
Physical activity, fitness, and longevity.
Progress in cardiovascular diseases·2026
Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.
Rheumatology (Oxford, England)·2026
Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.
The British journal of radiology·2026
One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.
Molecular medicine reports·2026